Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
134,369
-
Share change
-
+22,303
-
Total reported value
-
$1,921,346
-
Price per share
-
$14.29
-
Number of holders
-
14
-
Value change
-
+$272,976
-
Number of buys
-
7
-
Number of sells
-
5
Institutional Holders of OPIANT PHARMACEUTICALS INC - COM (OPNT) as of Q2 2018
As of 30 Jun 2018,
OPIANT PHARMACEUTICALS INC - COM (OPNT) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
134,369 shares.
The largest 10 holders included
VANGUARD GROUP INC, NORTHERN TRUST CORP, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, O'SHAUGHNESSY ASSET MANAGEMENT, LLC, ROYAL BANK OF CANADA, UBS Group AG, Federation des caisses Desjardins du Quebec, MORGAN STANLEY, and ROYCE & ASSOCIATES LP.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.